The QualityStocks Daily Tuesday, February 12th, 2019

Today's Top 3 StockMarketWatch

StocksToBuyNow (VMHG) +87.80%

BUYINS.NET (CASM) +54.14%

PoliticsAndMyPortfolio (PTX) +36.62%

The QualityStocks Daily Stock List

Nu-Med Plus, Inc. (NUMD)

Stockhouse, Wallet Investor, OTC Markets, Marketwired, Investing News, Street Insider, The StreetWise Reports, MarketWatch, The Street, Venture Line, Stockopedia, Business Insider, Morningstar, GuruFocus, Capital Cube, last10k, TradingView, Wallmine, and Stockwatch reported earlier on Nu-Med Plus, Inc. (NUMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nu-Med Plus, Inc. investigates and develops applications of Nitric Oxide technologies in the medical field. The OTCQB-listed Company formed to explore medical applications of newly developed technologies. Its strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. A medical device business, the Company is headquartered in Salt Lake City, Utah.

Inhaled Nitric Oxide (INO) is a medically essential gas. It is currently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), COPD and other pulmonary problems. Nu-Med Plus has the capability to deliver high purity Inhaled Nitric Oxide (INO) to the patient at point of use. INO may have future applications for an assortment of other diseases and medical complications that are now being investigated.

Nu-Med’s markets include neonatal complications, COPD, Tuberculosis, Malaria, and ARDS (a severe lung syndrome with no known cure). The Company’s team has developed a new Nitric Oxide (NO) gas delivery system. This system provides a continuous intra-breath concentration of therapeutic NO to medically supervised patients who are on ventilators in a hospital setting.

Last week, Nu-Med Plus announced it will receive its first clinical unit prototype and commence testing to verify design parameters. The design of the Nu-Med Plus clinical unit is to provide clinicians and care providers a number of key competitive advantages. The small unit fits easily into medical offices, emergency departments, as well as nursing homes. The unit offers a touch screen for ease-of-use and precision single-dose control. The clinical unit uses either a proprietary formula of nitric oxide generation or prefilled nitric oxide canisters.

Mr. Jeff Robins, Chief Executive Officer of Nu-Med Plus, stated, “The clinical unit multiplies the number of markets Nu-Med Plus is able to serve with our technology. The market-leading innovation offers providers and patients new treatment options, in new convenient environments, to address health issues that significantly impact quality of life and cost billions of dollars annually to treat.”

Nu-Med Plus, Inc. (NUMD), closed Tuesday's trading session at $0.65, even for the day. The average volume for the last 3 months is 207 and the stock's 52-week low/high is $0.40/$1.009.

chart

MediPharm Labs Corp. (MLCPF)

Small Cap Power, Trading View, Wallmine, New Cannabis Ventures, Stockwatch, Investing News, Stockhouse, MarketWatch, The Street, Marijuna.ca, InvestorsHub, technical420, PotStockNews, Highwater Financial, Barchart, GuruFocus, and Investors Hangout reported on MediPharm Labs Corp. (MLCPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MediPharm Labs Corp. is a leader in specialized, research-driven cannabis extraction and cannabinoid isolation. It is the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. The Company provides B2B (Business-to-Business) contract processing of cannabis to Canadian authorized licensed producers and appropriate worldwide growers. It supplies integrity-assured cannabis oil to qualified companies for sale under their own brand.

MediPharm Labs has its corporate office in Barrie, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQB. MediPharm Labs was awarded Start-up of the Year at the recent Canadian Cannabis Awards hosted by Lift & Co.

The Company is research-driven and centered on downstream secondary extraction methodology, distillation, as well as cannabinoid isolation and purification. Furthermore, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Via its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.

In January, MediPharm Labs announced that its wholly-owned subsidiary, MediPharm Labs, Inc. (MediPharm), entered into an initial three-year extraction agreement for the processing of dried cannabis to cannabis oil concentrates with TerrAscend Corp. (OTCQX: TRSSF). With this Agreement, TerrAscend will supply bulk quantities of dried cannabis to MediPharm for processing on a fee for service basis into bulk resin or other premium cannabis oil derivative products sold under TerrAscend brands.

Moreover, in January, MediPharm Labs announced that it signed three cannabis oil sales agreements, after its receipt of its sales license from Health Canada on November 9, 2018. The first large shipments of cannabis oil supply left MediPharm’s dock in December 2018 and were aggregately valued at greater than $10 million.

Today, MediPharm Labs announced that its MediPharm Labs, Inc. subsidiary entered into a major sales agreement with a foremost Licensed Producer to supply roughly $35 million of private label purified cannabis oil concentrates. With this Agreement, the Licensed Producer will immediately purchase upfront $7.66 million of cannabis oil concentrate from MediPharm Labs’ inventory in February 2019.

Also, the Licensed Producer will purchase a minimum of $27 million of cannabis oil concentrate over a 12-month period starting March 2019, with an option to purchase an additional $13.5 million over the same period. This brings the total potential aggregate value of the agreement to more than $48 million to February 2020.

MediPharm Labs Corp. (MLCPF), closed Tuesday's trading session at $1.96017, up 35.18%, on 514,451 volume with 715 trades. The average volume for the last 3 months is 21,688 and the stock's 52-week low/high is $0.9125/$1.98.

chart

Galaxy Next Generation, Inc. (GAXY)

Market Screener, Business Insider, Morningstar, Stockhouse, Street Insider, Corporate Information, Wallet Investor, GuruFocus, iwatchmarkets, Simply Wall St, Dividend Investor, Investors Hangout, and last10k reported on Galaxy Next Generation, Inc. (GAXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Next Generation, Inc. is a U.S. distributor of interactive learning technology hardware and software that create fully collaborative instructional environments. The Company’s products include its own private-label interactive touch screen panel and many other national and international branded peripheral and communication devices. Galaxy Next Generation has its corporate headquarters in Toccoa, Georgia. The Company lists on the OTC Markets Group’s OTCQB.

Galaxy Next Generation works together with educators to help them progress teaching and learning in their Connected Classrooms. This approach takes advantage of digital content, learning data, and one-of-a-kind technologies to create an immersive and interactive experience.

The Company’s products include Interactive Panels, Collaboration Devices, Panel Accessories, and Integrated PCs. Galaxy Next Generation’s distribution channel consists of 22-plus resellers across the United States who mainly sell the Company's products within the commercial and educational market. The K-12 education market is the largest customer base for the Company’s products - covering almost 90 percent of Galaxy's sales.

Last week, Galaxy Next Generation announced that effective February 6, 2019, it completed the transfer of the common stock of its wholly-owned subsidiary, FLCR Entertainment, Inc. The transfer was made in fulfillment of and in compliance with the terms of the Merger Agreement the Company entered on June 6, 2018, as reported on its current report on 8-K filed with the SEC (Securities and Exchange Commission) on that date. Galaxy reduced its Consolidated Debt by $5 Million.

Mr. Gary Lecroy, Chief Executive Officer of Galaxy Next Generation, said, “This is among the best things that has occurred for the company since we became public as it is, in essence, a new beginning that allows us to target all of our energies into what we do best.”

Today, Galaxy Next Generation announced the signing of three new resellers. These resellers will increase STEM learning for students in an ever-increasing list of States. The Company’s new resellers are Benecom Technologies, Focus Audio Video, and Rutland Low Voltage Systems.

Galaxy Next Generation, Inc. (GAXY), closed Tuesday's trading session at $2.70, up 18.42%, on 31,876 volume with 69 trades. The average volume for the last 3 months is 1,443 and the stock's 52-week low/high is $0.735/$75.95.

chart

Humanigen, Inc. (HGEN)

Amigo Bulls, InvestorsHub, Barchart, Investors Hangout, Financial Times, Stock Invest, Corporate Information, Insider Financial, The Street, TradingView, OTC Markets, Investopedia, and Proactive Investors reported previously on Humanigen, Inc. (HGEN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Humanigen, Inc. focuses on advancing medicines for patients with neglected and rare diseases via unique, accelerated business models. Lead compounds in the Company’s portfolio include the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. Derived from its Humaneered® platform, lenzilumab and ifabotuzumab are lead compounds in the portfolio of monoclonal antibodies with first-in-class mechanisms. OTCQB-listed, Humanigen is headquartered in Brisbane, California.

The Company pursues innovative science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. Lenzilumab has potential for the treatment of different rare diseases. These include hematologic cancers such as chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML).

Lenzilumab is a Humaneered® recombinant monoclonal antibody. It neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF). This is a crucial cytokine that drives the growth of certain hematologic malignancies.

The other important asset in Humanigen’s monoclonal antibody portfolio, ifabotuzumab, has been dosed in the first patient in an investigator-sponsored Phase 0/1 radio-labeled imaging trial in glioblastoma multiforme (GBM). Ifabotuzumab is a first-in-class, monoclonal antibody. It targets the EphA3 receptor tyrosine kinase created using the Company’s proprietary Humaneered® technology.

This past December, Humanigen announced that final results from the xenograft study of lenzilumab, a first-in-class anti-GM-CSF monoclonal antibody, were presented in the oral plenary session at the 2018 Annual Meeting of the American Society of Hematology, on December 3, 2018, by Rosalie Sterner from Mayo Clinic. The principal investigator for the study was Saad Kenderian, M.B., Ch.B., Mayo Clinic hematologist.

The abstract entitled “GM-CSF Blockade during Chimeric Antigen Receptor T Cell Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance Their Effector Functions” was published as a first edition paper by ‘blood’® in the November 21, 2018 edition. It is available online at www.bloodjournal.org.

Last month, Humanigen announced that new research was published in the December issue of the journal Cancers demonstrating that the EphA3 receptor, the novel target for Humanigen’s proprietary monoclonal antibody ifabotuzumab, is an attractive tumor-specific target for glioblastoma multiforme (GBM) therapy. In addition, the results suggest that ifabotuzumab may be therapeutically useful in the treatment of other solid tumors.

Dr. Cameron Durrant, Humanigen’s Chief Executive Officer, said, “Brain cancer sufferers have not seen meaningful increases in overall survival for decades. By targeting the tumor stem cells, stromal cells and neovasculature, we believe ifabotuzumab has the potential to emerge as a next-generation oncology therapy.”

Humanigen, Inc. (HGEN), closed Tuesday's trading session at $0.90, up 8.43%, on 1,710 volume with 5 trades. The average volume for the last 3 months is 4,950 and the stock's 52-week low/high is $0.27/$1.08.

chart

Kutcho Copper Corp. (KCCFF)

InvestorX, Junior Stock Review, Investors Hangout, The Prospector News, Mining & Energy, Wallet Investor, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Stock Orange, Resource World, Dividend Investor, Stockhouse, Barchart, Stockwatch, and MarketWatch reported previously on Kutcho Copper Corp. (KCCFF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Kutcho Copper Corp. concentrates on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. The Company’s intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. A resource development company, Kutcho Copper is headquartered in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is Kutcho’s 100 percent owned high grade copper-zinc development project in northern B.C. This Project is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho Copper has a Probable Reserve of 10.4 Mt grading 2.01% Cu and 3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves and substantially increase production capacity.

The Wheaton Precious Metals stream establishes a basis for a strong partnership and lessens financial risk of the Project. Furthermore, there is the potential for more discoveries via exploration. Kutcho Copper’s objective is to increase reserves from the present 10.4 Mt through existing resource conversion.

Kutcho Copper has launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, a global base and precious metals and concentrates trading company and an international financial institution providing banking services in the metals and mining industry. MineHub is a leading-edge technology company taking advantage of blockchain technology to develop a new generation of applications for the metals and mining industry.

Last month, MineHub Technologies and IBM announced a collaboration to use blockchain technology to help improve operational efficiencies, logistics and financing and decrease costs in the high-value mineral concentrates supply chain - from mine to end buyer. Kutcho Copper, Goldcorp, Inc., ING Bank, Ocean Partners USA, Inc. and Wheaton Precious Metals are working with mining technology company MineHub to build the new mining supply chain solution on top of the IBM Blockchain Platform.

In addition, in January, Kutcho Copper announced it appointed Mr. Michael Rapsch as Vice President of Corporate Communications. Mr. Rapsch has a decade of in-depth investor relations and corporate communications experience.  Before joining Kutcho Copper he held the position of Vice President, Corporate Communications at SilverCrest Metals, Inc. for the last three years.

Kutcho Copper Corp. (KCCFF), closed Tuesday's trading session at $0.242, down 3.85%, on 10,326 volume with 6 trades. The average volume for the last 3 months is 17,108 and the stock's 52-week low/high is $0.143/$0.759.

chart

Rebel Group, Inc. (REBL)

OTC Markets, Market Screener, InvestorsHub, MarketWatch, Investing, 4-Traders, The Street, Stockhouse, GuruFocus, Simply Wall St, Awesome Penny Stocks, Barchart, Wallet Investor, Ceo.ca, Penny Stock Hub, Morningstar, and YCharts reported earlier on Rebel Group, Inc. (REBL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rebel Group, Inc., by way of its subsidiaries, organizes, promotes, and hosts mixed martial arts (MMA) events in China and Singapore. The Company’s focus is on organizing, promoting and hosting MMA events that attract talented fighters from around the world. An MMA entertainment company, Rebel Group has its corporate headquarters in Singapore. Established in May 2013, the Company is a subsidiary of Total Glory International Limited. Rebel Group lists on the OTCQB.

The Company operates under the Rebel Fighting Championship (Rebel FC) brand. Rebel Group carries out its operations through managing events, fighters, ticket sales, sponsorships, and pay-per-view purchases. The Company produces and distributes its events via the internet and social media. It works to sell the rights to distribute videos of its MMA events to television stations.

Rebel FC hosts all its events with MMA stars from around the world. The Company’s aim is to bring martial arts back to its birthplace – China. Through bringing the biggest fights to China, REBEL FC provides a platform for Chinese MMA fighters to excel on the world MMA stage by pitting them against the best international fighters.

Rebel Group creates international events featuring a line-up of legendary worldwide stars. These include Miguel Torres of the U.S and Takeshi “Lion” Inoue of Japan, as well as MMA champions from China. These include Liu Wenbo, Tang Kai, Wang Sai, Ning Guangyou and China’s No.1 ranked Bantamweight fighter and Rebel FC Champion, Ayideng Jumayi.

Rebel FC's long-term strategy is to develop the full potential of MMA in China. In addition, the Company’s strategy is to promote the sport as a lifestyle that mainstream audiences can embrace. Focusing on its intent to expand in China, REBEL FC hosted an event on September 7, 2018 at Beijing's National Olympic Stadium. It was titled REBEL FC 9 - Battle for the Kingdom, and it showcased the best MMA fighters China has to offer.

Rebel earlier announced the appointment of Mr. Benjamin Cher to REBEL FC’s Board of Directors as an Independent Director. Mr. Cher is an experienced professional with greater than 15 years of experience in banking, private equity, strategic planning and general management. He is the Founder and Chief Executive Officer of Aetius Capital, a Singapore-based private investment firm.

Rebel Group, Inc. (REBL), closed Tuesday's trading session at $1.40, even for the day. The average volume for the last 3 months is 160 and the stock's 52-week low/high is $0.51/$3.75.

chart

The Pocket Shot Company (PCKK)

Wallet Investor, Wallstreet Online, Stockopedia, InvestorsHub, GuruFocus, Street Insider, Wallmine, Market Exclusive, Dividend Investor, Seeking Alpha, MarketWatch, Stockhouse, and Financial Content reported on The Pocket Shot Company (PCKK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Pocket Shot Company is a specialty alcohol beverage distribution company listed on the OTC Markets. Fundamentally a portable spirit enterprise, it designs, produces, and distributes hard liquor and other beverages in flexible single-serving pouches in the U.S. The Company offers Pocket Shot, which is a grab and go package for alcoholic beverages. Pocket Shot Company is based in Denver, Colorado.

The Company’s goal was to create a user friendly, safe, mass production style pouch that could hold a broad array of flavors. The Company offers Pocket Shot in bourbon, whiskey, rum, vodka, brandy, tequila, cherry vodka, cinnamon whiskey, peppermint schnapps, spiced rum, and cinnamon schnapps flavors.

Pocket Shot can be found in more than 25 states. It sells in thousands of stores. Pocket Shot Company also offers its products via online retailers.

Last month, The Pocket Shot Company announced it completed its anticipated merger with Pure Harvest Cannabis Producers. Pure Harvest is a privately held Nevada company led by a group of cannabis industry pioneers. This merger will immediately permit Pocket Shot to enter the fast expanding cannabis, hemp, and CBD industry.

The post-merger company will immediately concentrate on developing into a multi-state, seed-to-sale, vertically integrated cannabis and hemp producer and retailer under the Pure Harvest brand. The enhanced brand will now include a unique beverage line of premium CBD infused products for energy and sports recovery.

Yesterday, The Pocket Shot Company announced that its Pure Harvest Cannabis Producers, Inc. subsidiary executed a Letter of Intent (LOI) for a large scale cannabis/CBD processing and production joint venture (JV) in Colombia on a prime 200 hectare (494 acre) site. This gives Pocket Shot Company a premier footprint for processing and production for export of cannabis derivatives into major legal markets internationally. This project will be directed by a newly created wholly-owned subsidiary, Pure Harvest Colombia Partners Ltd, which is a Canadian corporation.

The Pocket Shot Company (PCKK), closed Tuesday's trading session at $1.30, down 35.00%, on 3,419 volume with 8 trades. The average volume for the last 3 months is 2,391 and the stock's 52-week low/high is $0.11/$2.20.

chart

Alpine 4 Technologies Ltd. (ALPP)

TradingView, InvestorsHub, OTC Markets, Stockhouse, and MarketWatch reported on Alpine 4 Technologies Ltd. (ALPP), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Alpine 4 Technologies Ltd. is a technology and manufacturing holding company headquartered in Phoenix, Arizona. It has business-related endeavors in Automotive Technologies, Electronics Manufacturing, Software and Data Technologies. The Company previously went by the name Alpine 4 Automotive Technologies Ltd. It changed its corporate name to Alpine 4 Technologies Ltd. in June of 2015. Established in 2014, Alpine 4 Technologies lists on the OTC Markets’ OTCQB.

Alpine 4’s emphasis is on how the adaptation of new technologies, even in brick and mortar businesses, can propel innovation. The heart of its acquisition strategy is its focus on existing smaller middle market operating companies with Revenues of $5 to $50 million.

The design of Alpine 4 Technologies is to allow its subsidiaries room to develop their own identities and synergistically prosper from inter-company resources and collaboration. Alpine 4 will own controlling interest in every subsidiary. In addition, it will have direct control over planning and management.

The Company’s subsidiaries and product groups include ALTIA; Quality Circuit Assembly (QCA); and Venture West Energy Services. ALTIA is an automotive products company. The Quality Circuit Assembly (QCA) subsidiary provides electronic contract manufacturing solutions delivered to its customers by way of strategic business partnerships. Venture West Energy Services concentrates on supporting the oil and gas industry in Texas, Oklahoma, and Arkansas.

Alpine 4 Technologies has started two pilots of SPECTRUMebos, a blockchain Enterprise Business Operating System, in its subsidiaries Quality Circuit Assembly (QCA) and ALTIA, LLC. SPECTRUMebos is an Enterprise Business Operating System (EBOS) developed by Alpine 4 Technologies.

SPECTRUMebos combines the key technology software mechanisms of Accounting and Financial Reporting of an Enterprise Resource Planning System (ERP), a Document Management System (DMS), a Business Intelligence (BI) platform and a Customer Resource Management (CRM) hub all tied to a management reporting and collaboration toolset.

Alpine 4 Technologies completed its acquisition of American Precision Fabricators, Inc. (APF) in 2018.  The acquisition adds to Alpine 4’s technology manufacturing sector play, which began in 2016 with its purchase of Quality Circuit Assembly (QCA). This is the fourth acquisition that Alpine 4 Technologies has made in two years.

For greater than two decades, APF has been an industry leader for customers in the OEM (original equipment manufacturing) markets, fabricating and manufacturing components and products for many Fortune 1000 customers.

Recently, Alpine 4 Technologies’ subsidiary, Quality Circuit Assembly (QCA), announced a manufacturing partnership with Cobalt Robotics. The addition of customers such as Cobalt fits the QCA strategy and will help boost 2018 revenue.

In 2016, Mr. Travis Deyle and Mr. Erik Schluntz founded Cobalt Robotics (San Mateo, California). Cobalt Robotics fills a gap in the spectrum of security solutions via its highly-trained remote Specialists and fleet of autonomous robots.

Alpine 4 Technologies Ltd. (ALPP), closed Tuesday's trading session at $0.0413, up 5.90%, on 238,862 volume with 20 trades. The average volume for the last 3 months is 18,250 and the stock's 52-week low/high is $0.032/$0.20.

chart

Atico Mining Corporation (ATCMF)

Junior Mining Network, OTC Markets, 4-Traders, Stockhouse, MarketWatch, InvestorsHub, Marketwired, Streetwise Reports, Investing News, Capital Cube, Barchart, The Street, and The Northern Miner reported on Atico Mining Corporation (ATCMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Atico Mining Corporation centers on exploring, developing, and mining copper and gold projects in Latin America. It focuses on developing and operating high margin midsized Cu-Au deposits. The Company has a proven team of mine developers and mine operators. Its main project is the El Roble mine in Colombia. Atico Mining is based in Vancouver, British Columbia.

The Company is in production and producing cash flow at the El Roble mine. El Roble is in Carmen De Atrato, Colombia. The deposit type is Mafic-Type Volcanic Massive Sulphide. Atico’s ownership of El Roble is 90 percent of the operating mine and surrounding claims.

El Roble is a 6,679-hectare project. It is a producing mine with an 800 Tonnes per day throughput capacity. The end product is CU (+AU, AG) concentrate.

Recent evaluations by Atico Mining identified high-grade mineralization below the lowest production levels at El Roble. These evaluations also defined a measured and indicated resource of 1.86 million tonnes grading 3.46 percent copper and 2.27 g/t gold.

In July, Atico Mining announced the completion of two IP-DAS surveys covering the area from northwestern Archie prospect through the mine to the southern Estrella target area that have indicated new exploration targets near and below the mine.

Mr. Fernando E. Ganoza, Atico Mining Chief Executive Officer, said: "The exploration work and drilling we have completed since late 2017 have returned encouraging results for the occurrence of massive sulphide mineralization at the El Roble property. These results confirm the need to continue drill testing the anomalous targets and merits scaling-up the drill program for the remainder of the year. We continue to believe the property remains highly prospective to host additional massive sulphide mineralization."

Recently, Atico Mining announced its operating results for the three months ended June 30, 2018 from its El Roble mine. Production for the quarter totaled 5.22 million pounds of copper and 2,596 ounces of gold in concentrates. This represents an increase of 1 percent for both copper and gold, respectively, over the same period the year prior.

Atico Mining Corporation (ATCMF), closed Tuesday's trading session at $0.27, up 6.93%, on 4,000 volume with 5 trades. The average volume for the last 3 months is 32,593 and the stock's 52-week low/high is $0.1681/$0.61.

chart

MariMed, Inc. (MRMD)

Stockhouse, Investors Hub, Marketbeat, Proactive Investor, The Street, Insider Financial, OTC Markets, and Daily Marijuana Observer reported on MariMed, Inc. (MRMD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

MariMed, Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation and production centers and dispensaries. The Company provides turnkey solutions to cannabis cultivators, producers, and dispensaries. It specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales.

MariMed is based in Newton, Massachusetts and the Company lists on the OTC Markets Group’s OTCQB. MariMed Inc. is one of the 17 top-performing public cannabis companies in the United States tracked on the U.S. Marijuana Index, (www.marijuanaindex.com).

MariMed is focusing solely on serving the fast growing $7 billion legal cannabis industry. Itis working to create precision dosed products to treat specific conditions. MariMed’s team has developed state-of-the-art and regulatory compliant facilities in many states. These facilities are replicable and scalable models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.

Cannabis experts, MariMed specializes in supporting the development of high quality state-licensed, medical cannabis dispensaries and cultivation facilities. The Company provides a comprehensive range of consulting services in the medical cannabis industry. It uses a systematic approach, from the permit and application process, to on-time operational readiness.

MariMed’s services include application assistance, real estate and safe access, build-out and continuing consultation, business acceleration solutions, and physician and patient outreach. MariMed Advisors, Inc. has a portfolio of high-quality branded products, product development plans, product packaging, as well as product licensing opportunities.

In 2017, MariMed announced the purchase of a 137,500 sq. ft. industrial building on 17 acres at 167 John Vertente Blvd., in the New Bedford, Massachusetts industrial park. It will develop approximately 70,000 sq. ft. into a full service, state-of-the-art medical cannabis cultivation and production facility. This has been leased to ARL Healthcare, Inc. (ARL), a Massachusetts not for profit corporation.

Recently, MariMed announced it acquired iRollie LLC. This includes its intellectual property (IP), clients, and its host of products and services. MariMed acquired iRollie and its executives in exchange for $600,000 in MariMed stock.

MariMed hired iRollie’s cofounders Mr. Luke Shepter and Mr. Joe Khoury to expand the iRollie business and to bring their expertise and services in house to support MariMed brands and clients.

Also recently, MariMed announced that it signed an exclusive worldwide licensing agreement with Vitiprints™ for the global production and distribution rights in all existing and future legal cannabis markets. This agreement extends to all cannabis products made using Vitiprints’ proprietary technology. This includes liquid ingredient formulation, printing process, and the resulting collection of dissolvable products.

MariMed expects to complete test marketing of the dissolvable product sets in a MariMed-managed facility within 90 days. Subsequently, it will launch in legal states across the nation. It will then expand internationally by way of sublicense agreements with qualified manufacturers and distributors. Products will be available on shelves as early as the end of Q4 2018.

MariMed, Inc. (MRMD), closed Tuesday's trading session at $3.89, down 2.11%, on 213,122 volume with 439 trades. The average volume for the last 3 months is 513,067 and the stock's 52-week low/high is $0.95/$5.80.

chart

Covalon Technologies Ltd. (CVALF)

Penny Stock Tweets, Stockhouse, Barchart, Wallet Investor, 4-Traders, InvestorsHub, CapitalCube, OTC Markets, TradingView, InvestorsHangout, Proactive Investor, Penny Stock Picks, and Stockwatch reported on Covalon Technologies Ltd. (CVALF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Covalon Technologies Ltd. is an advanced medical technologies company listed on the OTC Markets Group’s OTCQX. Covalon researches, develops and commercializes new healthcare technologies. Its patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon Technologies has its corporate office in Mississauga, Ontario.

The Company’s technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility. Its Advanced Wound Care line has been specially designed for the successful treatment of a broad array of wounds.

Regarding Infection Prevention, Covalon Technologies has its highly lubricious and top-quality antimicrobial protection SilverCoat™ Foley catheter. In addition, the Company has its dual antimicrobial silicone adhesive platform across the MediClear™ PreOp, SurgiClear™ and IV Clear™ brands.

Moreover, Covalon’s Perioperative Care brands, MediClear™ and SurgiClear™ offer a range of care throughout a patient’s surgical journey. Covalon has its Technology platforms. These are its Biomatrix Platform, its Antimicrobial Silicone Platform, and its Medical Coating Platform.

Covalon Technologies has established a Special Committee of the Board of Directors to evaluate potential acquisitions, strategic alliances, as well as partnerships. This is in response to the interest generated following the Company’s earlier announcement of its $100 million contract awards in the Middle East.

The Company reported Q2 Revenue of $5,727,275 and a Net Loss of $479,082 for the three months ended March 31st, 2018. It reported Revenue of $12,131,980 and Net Income of $44,263 for the six months ended March 31st, 2018.

Recently, Covalon Technologies announced that it entered into a new acquisition and operating banking credit facility with HSBC Bank Canada. This credit facility provides the Company with up to $17 million of credit.

In support of Covalon Technologies, Export Development Canada (EDC) has partnered with HSBC to provide partial guarantees under the banking facility. The credit facility will permit Covalon to fund its acquisition plans, which the Company stated are proceeding well.

Covalon Technologies Ltd. (CVALF), closed Tuesday's trading session at $3.98627, up 0.66%, on 1,200 volume with 3 trades. The average volume for the last 3 months is 3,363 and the stock's 52-week low/high is $2.55/$7.12.

chart

ProtoKinetix, Inc. (PKTX)

Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, SmallCapVoice, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Stock Market News Alert, HotOTC, StockEgg, and Round Up the Bulls reported earlier on ProtoKinetix, Inc. (PKTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company listed on the OTC Markets’ OTCQB. The Company has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™), which enhance engraftment and protection of transplanted cells utilized in regenerative medicine. ProtoKinetix has its corporate headquarters in Marietta, Ohio.

Because of the anti-inflammatory effect of AAGP™ molecules, the Company is presently targeting the direct treatment of diseases that have a significant inflammatory component. ProtoKinetix’s, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish.

The Company’s AAGP™ molecule is helping to considerably improve the efficacy of Cell Transplant Treatments for diabetes. ProtoKinetix has broad patent protection for its portfolio of anti-aging glycopeptides.

Its anti-aging glycopeptide is trademarked AAGP™. This is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP that has been found to have protective properties in nature.

The small size of AAGP™ enables it to penetrate cells. It allows it to pass through cell and capillary junctions in vivo. Also, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

ProtoKinetix and Proactive Immune Sciences entered into a joint research collaboration. The objective of the research is to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences.

ProtoKinetix announced this past January that it entered into a research agreement with The University of British Columbia (UBC), under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. The research agreement is to test and establish the effect of AAGP™ on monoclonal antibody production and bone marrow recovery.

Recently, ProtoKinetix announced that it executed a Material Transfer Agreement (MTA) with a reputed biotechnology company having several international offices on four continents. Under the MTA, ProtoKinetix and this company are working together to test the effects AAGP® have on three projects.

One project is Cryopreservation of Primary Mammalian Tissue Cells. A second project is Enhancing the Viability of Primary Mammalian Cells. The third project is Cell Lines Under Stressed Culture Conditions.

ProtoKinetix President and Chief Executive Officer, Mr. Clarence E. Smith said, “We are delighted to be collaborating with this reputed, international biotechnology company with facilities worldwide. If testing proves to be successful, this may give ProtoKinetix the first opportunity to license out AAGP®.”

ProtoKinetix, Inc. (PKTX), closed Tuesday's trading session at $0.07245, up 11.46%, on 7,408 volume with 3 trades. The average volume for the last 3 months is 23,644 and the stock's 52-week low/high is $0.0299/$0.1299.

chart

Real Goods Solar, Inc. (RGSE)

InvestorsHub, Investor Place, Stock News Gazette, Stock Twits, MarketWatch, Barchart, and TradingView reported on Real Goods Solar, Inc. (RGSE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Real Goods Solar, Inc.’s RGS Energy operates as a residential and small business commercial solar energy engineering, procurement, and construction company in the United States. The Company has installed greater than 25,000 solar energy systems for homes, businesses, schools, government facilities, and utilities throughout the nation. This has totaled over 260 megawatts of clean energy. Real Goods Solar (RGS Energy) is based in Denver, Colorado. RGS Energy is the Company’s registered trade name.

Additionally, the Company is the exclusive manufacturer of POWERHOUSE™. This is an inventive in-roof solar shingle utilizing technology developed by The Dow Chemical Company. RGS Energy entered into an exclusive domestic and worldwide license agreement with The Dow Chemical Company for the POWERHOUSE™ solar shingles system. RGS will lead all commercial activities for the product. This includes supply chain management, marketing, sales, installation, as well as warranty.

This solar shingle system has been installed on greater than 1,000 homes. RGS Energy and Dow Chemical anticipate UL product certification during Q1 of 2018. Pre-orders are being taken in advance of final written certification. RGS Energy’s plan is to begin sales and installation of POWERHOUSE™ 3.0 solar shingles immediately after.

Regarding RGS Energy’s business segments, the Solar Division consists of RGS Energy’s Residential and Sunetric business segments. The Corporate segment includes administrative costs associated with administrative services, legal settlements, legal, information systems, and accounting and finance. Beginning on September 29, 2017, POWERHOUSE™ is the Company’s new business segment.

This past November, RGS Energy announced the on-time launch of Solar 365™. This is the Company’s new mobile software and online dashboard suite. New and prospective customers can easily navigate Solar 365™. They can access information and documents concerning their planned solar installation wherever and whenever it is convenient. After installation, customers can easily access and view their cost savings and production stats in kilowatts and dollars earned if net metering.

In 2017, RGS Energy was chosen as exclusive installer for the Solarize Cranston, Solarize Granby, Solarize New Haven and Solarize North Haven communities.

For 2018, RGS Energy expects to attain UL Certification during Q3 and commence sales and installation of POWERHOUSE™ 3.0 solar shingles afterwards. Regarding its Solar Division, RGS Energy expects to realize break-even revenue, apart from POWERHOUSE™, in Q3.

Real Goods Solar, Inc. (RGSE), closed Tuesday's trading session at $0.456, up 3.12%, on 5,256,921 volume with 8,258 trades. The average volume for the last 3 months is 6,073,067 and the stock's 52-week low/high is $0.30/$1.64.

chart

AmpliTech Group, Inc. (AMPG)

Trading Wall St, fusionspicks, Jet-Life Penny Stocks, OTCMagic, Ascending Stocks, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, Wallstreetbuzz, AllPennyStocks, SmallCapVoice, PennyStocks24, Information Solutions Group, Pumps and Dumps, HoleinOneStocks.net, HotStockProfits, and Fortune Penny Stocks reported on AmpliTech Group, Inc. (AMPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and global, SATCOM, Space, and Military markets. Additionally, the Company provides consulting services to help with any microwave components or systems design problems. AmpliTech sells its products by way of sales representatives and distributors in North America, Europe, and Asia. OTCQB-listed, AmpliTech Group is based in Bohemia, New York.

The Company’s designs cover the frequency spectrum from 50 kHz to 40 GHz – eventually providing designs up to 100 GHz. AmpliTech can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs.

AmpliTech provides its customers with consulting services for their system development. In addition, the Company provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

AmpliTech utilizes the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. AmpliTech expects to release new products targeted at the wireless and satellite markets, which will provide advanced technology and performance.

AmpliTech Group announced in 2017 that it entered into a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

The emphasis of this JV is to develop an affordable mixed signal chipset that can be used at server/router level and also in mobile PDA applications to provide secure and encrypted communication with the goal of preventing hacking and cyber-attacks.

This JV will take advantage of AmpliTech's industry leadership and experience in RF/Microwave LNA technology and TN's Cyber-security Protocol technology to eliminate the widespread occurrence of corporate and individual cyber-attacks.

In November, Amplitech Group announced the filing of its 10-Q for Q3 2017. AmpliTech reported a decline in gross revenues of 24 percent versus the same period the year prior. The Company experienced its second consecutive quarter with reduced revenue.

However, AmpliTech continued its path towards enhancing and expanding its niche product line and technology through investing in research and development (R&D) in higher margin products for commercial applications. In addition, AmpliTech has invested substantially more into advertising and marketing than any other year in its history.

AmpliTech Group, Inc. (AMPG), closed Tuesday's trading session at $0.0369, up 11.82%, on 36,250 volume with 5 trades. The average volume for the last 3 months is 55,853 and the stock's 52-week low/high is $0.0265/$0.0748.

chart

The QualityStocks Company Corner

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. A new study has found that most Americans use medical marijuana in order to ease chronic pain. The study was aimed at finding out the exact reasons why people in the U.S. use medical marijuana, and whether those stated reasons have any scientific basis.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $5.547, up 0.67%, on 77,304 volume with 271 trades. The stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Precision Extraction Solutions ("Precision"), a market leader in cannabis and hemp extraction technology, has been named the exclusive equipment supplier of Canapar S.r.L. ("Canapar") for the development and outfitting of its flagship extraction facility in Sicily, Italy. On the heels of a $25 million CAD ($20 million USD) round of financing, that included a lead investment by Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF), the corporate venture capital platform of Canopy Growth Corporation (TSX: WEED, NYSE: CGC), a global leader in the cannabis sector, Canapar engaged Precision for the design and manufacturing of an industrial scale hemp extraction plant.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.73, up 6.29%, on 647,514 volume with 1,271 trades. The average volume for the last 3 months is 492,500 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a publication from Investorideas.com, examining how there are new supply and retail opportunities opening up in the cannabis sector with more relaxed legislation and outside industry support.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $4.4235, up 2.98%, on 275,349 volume with 842 trades. The average volume for the last 3 months is 189,112 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Regal Consulting looking at cannabis companies who produce consumer products that look ripe for a bull run. Also today, the company was highlighted in an article looking at how researchers in the UK have developed a new strain of cannabis that could help treat psychosis.  Recently, a British researcher, Dr. David Potter and his team, have turned their attention to developing a cannabis-based treatment for psychosis and related illnesses such as schizophrenia.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.50, up 4.17%, on 715,863 volume with 1,067 trades. The average volume for the last 3 months is 913,663 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures (OTC: NUGS) recently announced plans to establish a multi-acre cultivation facility in California to meet market demands.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.34, up 7.20%, on 140,705 volume with 103 trades. The average volume for the last 3 months is 113,434 and the stock's 52-week low/high is $1.02/$5.94.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) was featured today in the 420 with CNW by CannabisNewsWire. A new study has found that most Americans use medical marijuana in order to ease chronic pain. The study was aimed at finding out the exact reasons why people in the U.S. use medical marijuana, and whether those stated reasons have any scientific basis.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.3683, up 0.03%, on 17,865 volume with 14 trades. The average volume for the last 3 months is 37,218 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Cyberfort Software, Inc. (OTC: CYBF) is strengthening the online security of companies and end-users by focusing on innovative practices such as Content Filtering and Ad Blocking. The acquisition and development of the latest cybersecurity technology helps to tap into this increasingly large global market. A series of cyber-attacks like WannaCry or WannaCrypt ransomware attacks and Petya rocked the globe last year, while it’s difficult to predict what will happen this year, we can guess that cyber criminals will find new ways to carry out their attacks.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.20, up 33.33%, on 40,189 volume with 26 trades. The average volume for the last 3 months is 19,865 and the stock's 52-week low/high is $0.051/$69.00.

Recent News

chart

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN)

The QualityStocks Daily Newsletter would like to spotlight Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN).

The latest market dynamics will undoubtedly impact industry representatives like Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN). Black Iron is a Canadian iron ore exploration and development company that’s working on advancing production at its wholly owned Shymanivske Iron Ore Project. The site is located in central Ukraine and is surrounded by five operating iron ore mines owned by majors including ArcelorMittal and Metinvest. Also today, NetworkNewsWire released a NetworkNewsBreaks further detailing how is focused on the development of its Shymanivske iron ore deposit located in Kryvyi Rih, Ukraine. To view the full article, visit: http://nnw.fm/0rMrF.

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) is a Canadian iron ore exploration and development company advancing to production its wholly owned Shymanivske Iron Ore Project, located in Krivyi Rih, Ukraine. Black Iron’s Shymanivske project is situated in the southern part of the historic KrivBass iron ore mining district, a highly developed iron ore mining region with well-established infrastructure and nearby skilled labor forces. Surrounded by seven producing iron ore mines, the Shymanivske project will produce an ultra-high-grade, 68-percent iron ore concentrate with few impurities at very low cost.

The Market

Iron ore concentrates are one of the essential raw materials used by the steel industry to either make sinter or highly valued pellets. Black Iron’s concentrate can be used in either application and is an ideal source to make pellets since it does not need to be ground finer and contains very few impurities. According to the CRU Group, an internationally recognized top global business intelligence provider and consultancy specializing in commodities, there is a growing global shortage of pellet feed resulting in a supply/demand gap of 133Mt against the current base of approximately 400Mt consumed by 2035. According to a recent report issued by Zion Market Research, the global iron ore pellets market was valued at around US$25.22 billion in 2017 and is expected to reach US$50.12 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1 percent between 2018 and 2024 (http://nnw.fm/2vaDR).

Countries around the world, most notably China (http://nnw.fm/Je8gs), have instituted regulatory changes to curb polluting emissions from steel mills through numerous methods, including encouraging a shift to higher grade iron feed products such as pellets as less coal needs to be burnt per ton of steel produced.

Shymanivske Project

Black Iron’s Shymanivske’s project, which is expected to produce ultra-high-grade 68 percent iron content pellet feed iron concentrate, is generating significant interest from steel mills and global commodity trading houses. Use of ultra-high-grade 68-percent iron content product in the production of steel is a value-added product to customers since it increases blast furnace productivity and reduces greenhouse gas emissions generated per ton of steel produced.

The project’s proximity to rail lines (1 mile), electrical power (20 miles), sea ports (140 to 260 miles) and a skilled workforce (6 miles) significantly reduces the up-front construction costs and allows for the mine to be built in a phased approach. The Shymanivske project has been ranked by the CRU Group in the lowest position of the business cost curve for pellet feed projects currently under development and as the second lowest in capital intensity (construction capital divided by annual production) within CRU Group’s extensive database (http://nnw.fm/3MXsT). This low-cost position makes the project economics very robust to any shocks in iron ore price while providing a very high return at current and forecast prices.

Black Iron continues to advance its project on several fronts including construction funding and off-take agreements (http://nnw.fm/tQ4g2). Discussions with Ukraine’s Ministry of Defense to transfer a parcel of land required by the company for location of its processing plant, waste rock and tailings are nearing finalization, as are discussions with the Kryviy Rih City Council to lease a portion of the surface rights currently under that body’s control. The recent engagement of Ivan Markovich as Black Iron’s Vice President of Government and Community Relations will assist the company in these endeavors given his extensive network of relationships with senior Ukraine government officials.

The Shymanivske project holds a mining allotment permit for a large iron ore deposit with a NI 43-101 compliant resource estimated to contain 646 Mt (million tons) Measured and Indicated mineral resources, consisting of 355 Mt Measured mineral resources grading 31.6% total iron and 18.8% magnetic iron, and Indicated mineral resources of 290 Mt grading 31.1% total iron and 17.9% magnetic iron, using a cut-off grade of 10% magnetic iron. Additionally, there are 188 Mt of Inferred mineral resources grading 30.1% total iron and 18.4% magnetic iron.

Full mineral resource details and project economics can be found in the NI 43-101 compliant technical report entitled “Preliminary Economic Assessment of the Re-scoped Shymanivske Iron Ore Deposit” effective November 21, 2017, under the Company’s profile on SEDAR at?www.sedar.com.

Management

Black Iron’s management and board of directors is stacked with experts well-versed in successfully building and operating iron ore projects. CEO Matt Simpson, P.Eng. is the former general manager of Mining for Rio Tinto’s Iron Core Company of Canada and worked for Hatch designing global metallurgical refineries. He is also a Qualified Person as defined by NI 43-101. Chairman Bruce Humphrey is the former COO of GoldCorp and former chairman of Consolidated Thompson Iron Ore mines which was sold to Cliff’s resources for US$4.9 billion.

Les Kwasik, COO, has over 40 years of hands-on experience building and operating mines globally with companies such as INCO (VALE) and Xstrata (Glencore). Paul Bozoki, CFO, is the former CFO of CD Capital Partners, operating in the Ukraine. Bill Hart, senior vice president of corporate development, has over 30 years of experience selling iron ore while working for Rio Tinto, Cliffs Natural Resources and most recently Roy Hill Holdings Ltd. Ivan Markovich was recently engaged in the capacity of Black Iron’s vice president of Government and Community Relations to leverage his extensive network of relationships with senior Ukraine government officials.

Black Iron Inc. (BKIRF), closed the day's trading session at $0.0653, up 0.46%, on 159,152 volume with 8 trades. The average volume for the last 3 months is 11,301 and the stock's 52-week low/high is $0.0285/$0.0939.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (OTCMKTS: DVLP), an emerging leader in the Cannabis, Hemp, and CBD marketplace, is excited to announce significant progress toward the establishment of its new high-capacity CBD extraction and production facility in Colorado, including an approaching equipment order for a best-in-class supercritical CO2 extraction system (rather than an ethanol-based system) to drive the highest purity levels in end production.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.018, up 6.41%, on 843,631 volume with 51 trades. The average volume for the last 3 months is 630,143 and the stock's 52-week low/high is $0.0122/$0.14.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Smart energy technology company Kontrol Energy (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) offers a suite of smart products and services that enables its clients to maximize their energy savings. To view the full article, visit: http://nnw.fm/iV3vT.

Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.60, even for the day, on 13,000 volume with 3 trades. The average volume for the last 3 months is 18,118 and the stock's 52-week low/high is $0.46/$1.35.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) ("BriaCell" or the "Company"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, today announces the appointment of Jamieson Bondarenko to the Company's Board of Directors.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.07, even for the day. The average volume for the last 3 months is 16,118 and the stock's 52-week low/high is $0.0495/$0.135.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announced the release of its financial and operating results for the three and six months ended December 31, 2018. Including highlights such as revenue of $7.72 million, reflecting a 359 percent increase from Q2 2018 and a 50 percent increase from Q1 2019. Also today, the company was highlighted looking at how researchers in the UK have developed a new strain of cannabis that could help treat psychosis.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.425, off by 1.72%, on 516,635 volume with 662 trades. The average volume for the last 3 months is 421,496 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Sharing Services, Inc. (SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services Inc. (OTCQB: SHRV) is building on the successes of a blockbuster year as it looks ahead to 2019’s blue horizons for the entrepreneurship that keeps global commerce vibrant.

Sharing Services, Inc. (SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders –  Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.26, off by 3.70%, on 2,045 volume with 2 trades. The average volume for the last 3 months is 42,787 and the stock's 52-week low/high is $0.125/$0.59.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.42561, up 1.34%, on 17,383 volume with 18 trades. The average volume for the last 3 months is 15,165 and the stock's 52-week low/high is $0.035/$0.579.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.